HBV-IN-12

2724229-06-3

12352005

HBV

Reference compound

Anti-infection

COVID-19-anti-virus

Infection

https://www.medchemexpress.com/hbv-in-12.html

10 mM in DMSO

CC(C)([C@H]1N2C(C3=C(OC1)C=C(OCCCOC)C4=C3OCO4)=CC(C(C(O)=O)=C2)=O)C

C23H27NO8

445.46

[1]Tetracyclic compound as hepatitis b surface antigen inhibitor. WO2021204252A1.

Room temperature

Reference compound1

No Development Reported